MedTrace Logo

Termination of Persistent Atrial Fibrillation by Catheter Ablation

NCT04958928 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2021-07-12

No results posted yet for this study

Summary

This is a prospective, multicenter, cohort study aims to demonstrate the role of termination of AF in ablation for persistent atrial fibrillation, and evaluate the clinical outcomes in patients with or without AF termination.

Conditions

Interventions

PROCEDURE

Catheter ablation

All patients received radiofrequncy ablation.

Sponsors & Collaborators

  • Wuhan Central Hospital

    collaborator OTHER

  • Ruijin Hospital

    collaborator OTHER

  • Beijing Chao Yang Hospital

    collaborator OTHER

  • The Third Xiangya Hospital of Central South University

    collaborator OTHER

  • The First Affiliated Hospital of Dalian Medical University

    collaborator OTHER

  • Xiamen Cardiovascular Hospital, Xiamen University

    collaborator OTHER

  • The Third People's Hospital of Chengdu

    collaborator OTHER

  • Shanghai Chest Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-01
Primary Completion
2023-08-01
Completion
2023-08-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04958928 on ClinicalTrials.gov